Latest News | Humane Genomics

Update on selective replication

January 9, 2026 • pete

When we originally introduced the concept of selective replication over two years ago, we had promising ideas and some early data. Today, we have robust experimental results and a much clearer picture of how selective replication can be engineered reliably in RNA viruses. Back then …

Introducing Jason

January 8, 2026 • pete

My name is Jason, and I’m a product of Southern California, the ’90s, and of course, my parents. I spent most of my childhood playing soccer, whether outside kicking a ball or inside holding an Xbox controller…

Announcing Manufacturing Partnership with Genezen

November 12, 2025 • pete

Today, we’re thrilled to share a major milestone for Humane Genomics: we’ve partnered with Genezen to begin process transfer and cGMP (Current Good Manufacturing Practice) manufacturing of our lead oncolytic virus candidate for hepatoblastoma. This marks a big step forward in our mission to bring precision-engineered viral therapies to patients with cancer…

New Home at Alexandria LaunchLabs

July 3, 2025 • Rupsa Basu

We have moved from our founding location at BioLabs@NYU Langone to Alexandria LaunchLabs, a leading life sciences innovation space in New York City. This move marks another step forward in our mission to develop next-generation oncolytic viruses for cancer therapy. Why This Move Matters Relocating our lab, to us, is more than a logistical undertaking—it […]

Reflections from AACR 2025: Advancing Oncolytic Viral Therapies (OVTs)

May 19, 2025 • Chad Moles

We recently had the opportunity to attend the 2025 American Association for Cancer Research (AACR) conference in Chicago. It is one of the largest and most prestigious gatherings in the world for cancer researchers, clinicians, and biotech companies. It was an invaluable experience—an opportunity not only to present our latest findings but also to connect […]

Showcasing data on our oncolytic viral therapy at AACR 2025

April 22, 2025 • Chad Moles

We showcase breakthrough data on our engineered oncolytic viral therapy, a first-in-class for pediatric liver cancer. We are excited to share that Humane Genomics is returning to the American Association for Cancer Research (AACR) annual meeting for the third time! With over 23,000 attendees (in 2024), AACR is the largest gathering of cancer researchers, clinicians, […]

Announcing our Series Seed financing

February 12, 2025 • pete

Six years ago, I had dinner with my friend and co-founder Andrew Hessel and he told me something that blew my mind: it is possible to 3D print DNA. With this technology, we could engineer viruses for all kinds of purposes. One of the most compelling is to use these viruses as cancer therapies. My […]

Introduction – Manal

January 13, 2025 • pete

Manal Farhat Tell me a bit about yourself. Hi there! I’m Manal, a born and bred New Yorker. Being a true child of the diaspora, I also spent a chunk of my life in Lebanon, my parents’ homeland. I’m a self-professed nerd (and proud), so in retrospect, it doesn’t seem too surprising that I eventually […]

Improving the success rate of engineering RNA viruses

November 21, 2024 • Chad Moles

In our previous post on this topic, we introduced the details on how to make a replicating RNA virus from its genome (DNA). In this post, we want to zoom in on the details a bit more and share how we have improved the success rate of engineering viruses to over 70%. If you have […]

The Role of miRNA in Modern Medicine and the Nobel Prize Recognition

October 7, 2024 • pete

Today, the 2024 Nobel Prize in Medicine was awarded to Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNAs (miRNAs). This discovery has transformed our understanding of how cells regulate genes and opened new possibilities for diagnosing and treating diseases. But what exactly are miRNAs, and why are they so significant? What Are […]